Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 843 results for "Novartis Company"

Novartis partners with Mereo BioPharma to enhance novel drug portfolio
Bio Spectrum Asia

Novartis swaps three mid stage clinical assets with Mereo BioP...

Novartis, a global healthcare company, announced a swap of clinical assets for equity with Mereo BioPharma Group Ltd. The deal involves compounds in areas of unmet medical need including BPS-804, to improve bone density in brittle bone syndrome, an ... PharmaBiz, 2 days ago
Bio Spectrum Asia

CSL progresses on Novartis influenza vaccine biz acquisition

Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with the acquisition of the influenza vaccines business of Novartis and the new CSL subsidiary resulting from the acquisition will be ...
 Bio Spectrum Asia2 days ago Update on Novartis influenza vaccines acquisition  FirstWord Pharma2 days ago CSL : Update on Novartis influenza vaccines acquisition  4 Traders2 days ago
India Infoline

MorphoSys receives milestone payment from Novartis in blood disorders programme

MorphoSys AG, a biotechnology company focused on the research and development of fully human antibodies, has received a milestone payment from Novartis to start a phase 1 clinical trial of a HuCAL antibody in the field of blood disorders. This ...
 PharmaBiz1 week ago Analyst: J&J's Stelara to challenge Novartis in ankylosing spondylitis  FiercePharma6 days ago Novartis, India face off over patent-protection future there  FiercePharma5 days ago Novartis India plunges 13% on denial to delising buzz  Money Control1 month ago
Money Control

Novartis India Q1 net profit falls 6% to Rs 13.45 crore

The company had posted a net profit of Rs 14.31 crore in the corresponding period of the previous fiscal, Novartis India said in a filing to the BSE.
 Money Control1 week ago Novartis India's net profit falls in Q1  Prokerala1 week ago Novartis India to consider dividend on May 27, 2015  Money Control2 months ago

Novartis India Q4 net up 2 folds at Rs 51.94 cr

During the quarter under review, the company said its core pharmaceutical business recorded a total income of Rs 144.4 crore as against Rs 137.7 crore in the year-ago period.
 Money Control2 months ago Novartis reports 2Q net sales of $12.7 billion, growth product increase  Orthopedics Today1 week ago
Business Standard

Patent refused to Novartis on anti-diabetes formulation

The Patent Office (PO) in Delhi, has refused to grant a patent to Novartis, the Swiss pharmaceutical company, for a modified release formulation of its diabetes drug, Vildagliptin, which it markets under the brand name of Galvus. Novartis has been engaged in ...
 Business Standard2 months ago US co Abraxis denied patent on cancer drug  Times of India2 months ago

EPGL and Novartis to Enter Discussions

Company News: Page (1) of 1 - 07/30/15 print page (July 30, 2015) IRVINE, Calif. , July 30, 2015 /PRNewswire/ -- EP Global Communications, Inc. (Public OTC: EPGL)announced today that Novartis /Alcon executives have recently ...
 DV Format3 days ago EP Global Communications, Inc. (EPGL: OTC Pink Current) | EPGL and Novartis to Enter Discussions  OTC Markets3 days ago See what's new at SAPinsider's Financials 2015, BI 2015, GRC 2015, and HANA 2015 in Singapore  SAP Insider3 days ago
Pharma Letter

Novartis partners with UK biotech company Mereo BioPharma29-07-2015

Related news from the web 08-07-2014 26-06-2014 18-06-2014 Related Companies Swiss pharma major Novartis has announced a swap of clinical assets for equity with UK-based specialty… In order to access this content you need to be logged ...
 Pharma Letter3 days ago Novartis AG (ADR) (NYSE:NVS) Mereo BioPharma Group Ltd  Live Trading News4 days ago Novartis spins out 3 drugs to a biotech startup with $119M in VC backing  FierceBiotech4 days ago Novartis forms Mereo as UK biotech spin-off  Pharmafile4 days ago

Mereo Debuts With $119 Million and Mid-Stage Product Portfolio From Novartis AG (NVS) 7/29/2015

Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company LONDON , July 29, 2015 /PRNewswire/ -- A n ew UK company focused ...
 ClinicSpace4 days ago Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company  Wall Street Select4 days ago

Novartis's Adjusted Earnings per Share Declined 7% in 2Q15

. The company achieved adjusted EPS of $1.27 for 2Q15, ~7% lower than
 Yahoo! Canada5 days ago Why Sandoz Revenues Were Important for Novartis in 2Q15  Yahoo! Finance4 days ago Why Novartis's Revenues Declined Marginally  Yahoo! Finance5 days ago Novartis's Shares Fall after 2Q15 Earnings  Yahoo! Finance3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less